ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
Product List
Home / ARPOD-CV DRY SYP
ARPOD-CV DRY SYP

XTROCIN

Product Packing: 5 GM

Product Composition: Mupirocin 2%

Product Price: MRP : 103.13

XTROCIN

Mupirocin 2% | OINT 5 GM

XTROCIN is a topical ointment containing Mupirocin 2%. Mupirocin is a topical antibacterial used for selected superficial bacterial skin infections caused by susceptible organisms. It should be used only for approved indications and for the recommended duration to support appropriate antimicrobial use.

Mupirocin inhibits bacterial isoleucyl-transfer RNA synthetase, interfering with bacterial protein synthesis. Correct diagnosis is important because Mupirocin does not treat fungal or viral skin infections, and unnecessary or prolonged use can promote resistance or overgrowth of non-susceptible organisms.

Composition

Each approved measured quantity contains:

·         Mupirocin - 2%

·         Ointment base - q.s.

·         Exact Mupirocin form/equivalence, ointment base, preservatives, excipients and complete formulation specifications must be verified from the current approved product label.

Dosage form: Topical Ointment

Pack size: 5 gm

Uses of XTROCIN

XTROCIN may be prescribed for selected superficial bacterial skin infections where Mupirocin-sensitive organisms are suspected or confirmed and the indication is approved.

·         Provides topical antibacterial activity against susceptible bacteria

·         May be used in approved localized bacterial skin infections such as appropriate cases of impetigo

·         May be used for other approved superficial bacterial skin indications when specifically directed by a healthcare professional

·         It is not intended for fungal, viral or undiagnosed skin conditions and should not be used indiscriminately

Rapidly spreading redness, fever, severe pain, deep infection, abscess, extensive wounds, facial/eye involvement or failure to improve requires professional assessment.

How XTROCIN Works

XTROCIN provides targeted topical antibacterial action:

Mupirocin: An antibacterial that selectively inhibits bacterial isoleucyl-tRNA synthetase.

This blocks incorporation of isoleucine into bacterial proteins and interferes with protein synthesis.

At appropriate local concentrations, Mupirocin acts against susceptible organisms associated with approved superficial skin infections.

It does not provide antifungal or antiviral activity, so correct diagnosis is essential.

Clinical response and safety depend on organism susceptibility, infection depth and extent, application site, treatment duration and individual patient factors.

 

Dosage and Direction for Use

 

Apply XTROCIN only according to the current approved product label or healthcare professional's prescription. Application amount, frequency and treatment duration must not be inferred from the 2% strength alone.

Clean and dry the affected area as directed, then apply the prescribed amount using hygienic technique. Wash hands before and after application unless the hands are being treated.

Avoid eyes, mouth and other mucous membranes unless the specific formulation is approved for such use. Do not mix with other topical preparations on the same site unless professionally advised.

Complete the prescribed course and do not extend treatment unnecessarily. Reassessment is important if symptoms worsen or fail to improve within the expected period.

Possible Side Effects

 

Possible adverse effects may include:

·         Local burning, stinging, pain or irritation at the application site

·         Itching, redness, dryness, rash or contact dermatitis

·         Hypersensitivity reactions may occur and can rarely be serious

·         Prolonged use may result in overgrowth of non-susceptible organisms, including fungi

·         Systemic absorption is generally limited with appropriate topical use, but may increase when applied extensively or to damaged skin depending on the formulation.

Stop use and seek prompt medical advice for severe allergy, rapidly worsening infection, extensive rash or other serious symptoms.

Precautions and Contraindications

Avoid use in patients with known hypersensitivity to Mupirocin or any formulation excipient.

·         Use only for approved bacterial skin indications; do not use routinely for undiagnosed rashes or non-bacterial conditions.

·         Avoid prolonged or repeated courses without professional review because inappropriate antibacterial use can contribute to resistance.

·         Use caution with extensive open wounds, burns or severely damaged skin; absorption and suitability may depend on the ointment base and approved formulation.

·         Some Mupirocin ointment formulations may contain polyethylene glycol; if present, extensive use on damaged skin may require additional caution in moderate or severe renal impairment. Verify the actual base before applying this warning.

·         Pregnancy, breastfeeding and pediatric use should follow the approved label and professional advice. If used near the breast, avoid infant exposure and follow appropriate cleansing instructions.

·         Check the exact Mupirocin form/equivalence, approved application sites, age range, maximum duration, ointment base/excipients, storage conditions and prescription/regulatory status on the approved label.

·         Keep out of reach of children and use only by the approved topical route.

·         Drug Interaction Considerations

·         Clinically significant systemic drug interactions are not generally expected with limited topical use, but other creams or ointments applied to the same site may dilute Mupirocin or alter its stability and effectiveness.

·         Tell the healthcare professional about other topical medicines, antiseptics or wound products being used on the same area before combining treatments.

Business Growth Opportunity with XTROCIN

XTROCIN offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add a Mupirocin 2% topical antibacterial ointment to an appropriately licensed dermatology and wound-care portfolio.

Promotion must remain strictly consistent with approved bacterial indications, prescription status, treatment duration, antimicrobial stewardship principles, warnings and applicable regulations.

 

Key Business Advantages

·         Mupirocin 2% topical antibacterial formulation

·         Focused single-active antibacterial product

·         Convenient ointment dosage form

·         5 gm pack

·         Suitable addition to an appropriately licensed dermatology and wound-care portfolio

·         Opportunity for ethical, indication-focused promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for XTROCIN

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for XTROCIN in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids consistent with approved claims

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical product portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for XTROCIN and other quality-focused healthcare products.

Third-Party Manufacturing Support for Topical Ointments

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of Mupirocin ointments similar to XTROCIN under their own brand, subject to applicable drug licensing, regulatory and manufacturing requirements.

Our third-party manufacturing support may include:

·         Approved Mupirocin 2% formulation and 5 gm pack configuration support, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed facilities

·         Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies seeking to expand an appropriately licensed dermatology and topical antibacterial portfolio.

Frequently Asked Questions About XTROCIN

1. What is XTROCIN?

XTROCIN is a 5 gm topical ointment containing Mupirocin 2% according to the supplied product brief.

2. What is Mupirocin?

Mupirocin is a topical antibacterial that inhibits bacterial isoleucyl-tRNA synthetase and interferes with protein synthesis in susceptible bacteria.

3. What is XTROCIN used for?

It may be used for selected approved superficial bacterial skin infections caused by susceptible organisms. The exact indication should follow the current approved label and professional diagnosis.

4. Does XTROCIN treat fungal or viral infections?

No. Mupirocin is antibacterial and does not treat fungal or viral skin infections.

5. Can XTROCIN be used for a long time?

It should be used only for the approved or prescribed duration. Unnecessary prolonged or repeated use can encourage resistance or overgrowth of non-susceptible organisms.

6. How should XTROCIN be used?

Apply only in the amount, frequency, application site and duration stated on the approved label or prescribed by a healthcare professional.

7. Is a PCD Pharma Franchise available for XTROCIN?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Mupirocin 2% ointment may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable licensing, manufacturing and regulatory requirements.

Disclaimer

XTROCIN product information in this document is for general professional and business information. The supplied product brief states Mupirocin 2%, OINT 5 GM. Exact Mupirocin form/equivalence, approved indications, application amount/frequency, treatment duration, age restrictions, contraindications, warnings, antimicrobial susceptibility considerations, prescription/regulatory status, ointment base/excipients, manufacturing specifications and storage instructions must be verified against the current approved product label before manufacture, promotion, recommending, dispensing or use. Mupirocin should be used only for appropriate bacterial indications and unnecessary or prolonged antibacterial use should be avoided. This document is not a substitute for professional medical advice.

Contact